MREO
Mereo BioPharma
MREO
MREO
90 hedge funds and large institutions have $403M invested in Mereo BioPharma in 2024 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 20 increasing their positions, 25 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
7% less capital invested
Capital invested by funds: $435M → $403M (-$31.6M)
20% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 25
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
90
Holding in Top 10
2
Calls
$3.02M
Puts
$1.84M
Top Buyers
| 1 | +$16.7M | |
| 2 | +$9.27M | |
| 3 | +$4.22M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$4.03M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$3.38M |
Top Sellers
| 1 | -$5M | |
| 2 | -$3.5M | |
| 3 | -$1.8M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$1.68M |
| 5 |
6CM
683 Capital Management
New York
|
-$1.05M |